Tag: <span>metastatic renal cell cancer (mRCC)</span>

Home / metastatic renal cell cancer (mRCC)
Post

Drug combination shows better tolerance and effectiveness in metastatic renal cell cancer

A new cooperative research study including Norris Cotton Cancer Center’s Lionel Lewis, MB BCh, MD, finds that nivolumab plus ipilimumab therapy demonstrated manageable safety, notable antitumor activity, and durable responses with promising long term overall survival in patients with metastatic renal cell cancer (mRCC). The multi-institutional study known as the CheckMate 016 study evaluated the...